Rezolute, Inc. (RZLT)
NASDAQ: RZLT · Real-Time Price · USD
3.170
-0.040 (-1.25%)
At close: May 11, 2026, 4:00 PM EDT
3.170
0.00 (0.00%)
Pre-market: May 12, 2026, 4:07 AM EDT
Rezolute Employees
Rezolute had 75 employees as of December 31, 2025. The number of employees increased by 11 or 17.19% compared to the same quarter last year.
Employees
75
Change
11
Growth
17.19%
Revenue / Employee
n/a
Profits / Employee
-$1,123,040
Market Cap
329.27M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 75 | 11 | 17.19% |
| Sep 30, 2025 | 75 | 57 | 316.67% |
| Jun 30, 2025 | 71 | 12 | 20.34% |
| Mar 31, 2025 | 68 | 13 | 23.64% |
| Dec 31, 2024 | 64 | 7 | 12.28% |
| Sep 30, 2024 | 18 | -32 | -64.00% |
| Jun 30, 2024 | 59 | 8 | 15.69% |
| Mar 31, 2024 | 55 | 8 | 17.02% |
| Dec 31, 2023 | 57 | 9 | 18.75% |
| Sep 30, 2023 | 50 | 8 | 19.05% |
| Jun 30, 2023 | 51 | 9 | 21.43% |
| Mar 31, 2023 | 47 | 5 | 11.90% |
| Dec 31, 2022 | 48 | - | - |
| Jun 30, 2022 | 42 | 16 | 61.54% |
| Jun 30, 2021 | 26 | 3 | 13.04% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Replimune Group | 479 |
| Bicycle Therapeutics | 288 |
| Abeona Therapeutics | 226 |
| C4 Therapeutics | 104 |
| Neumora Therapeutics | 96 |
| Silence Therapeutics | 88 |
| Lineage Cell Therapeutics | 77 |
| Immuneering | 53 |
RZLT News
- 1 day ago - Rezolute to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 10 days ago - Rezolute presents results from Phase 3 sunRIZE study of ersodetug at PES 2026 - TheFly
- 10 days ago - Rezolute Announces Oral Presentation of Results From its Phase 3 sunRIZE Study of Ersodetug in Patients with Congenital Hyperinsulinism at the Pediatric Endocrine Society Annual Meeting - GlobeNewsWire
- 17 days ago - Rezolute, Inc. Investigated by the Portnoy Law Firm - GlobeNewsWire
- 21 days ago - Rezolute to Present Results from its Phase 3 sunRIZE Study in Congenital Hyperinsulinism at the Pediatric Endocrine Society (PES) Annual Meeting - GlobeNewsWire
- 6 weeks ago - Wedbush upgrades Rezolute as worst case scenario seems unlikely for cHI - TheFly
- 6 weeks ago - Rezolute upgraded to Outperform from Neutral at Wedbush - TheFly
- 6 weeks ago - Rezolute provides update on sunRIZE study following Type B meeting with FDA - TheFly